251 related articles for article (PubMed ID: 28494969)
1. Rate-Dependent Role of I
Aguilar M; Feng J; Vigmond E; Comtois P; Nattel S
Biophys J; 2017 May; 112(9):1997-2010. PubMed ID: 28494969
[TBL] [Abstract][Full Text] [Related]
2. Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model.
Courtemanche M; Ramirez RJ; Nattel S
Cardiovasc Res; 1999 May; 42(2):477-89. PubMed ID: 10533583
[TBL] [Abstract][Full Text] [Related]
3. Revealing kinetics and state-dependent binding properties of I
Ellinwood N; Dobrev D; Morotti S; Grandi E
Chaos; 2017 Sep; 27(9):093918. PubMed ID: 28964116
[TBL] [Abstract][Full Text] [Related]
4. Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes.
Wang Z; Fermini B; Nattel S
J Pharmacol Exp Ther; 1995 Jan; 272(1):184-96. PubMed ID: 7815332
[TBL] [Abstract][Full Text] [Related]
5. In silico study on the effects of IKur block kinetics on prolongation of human action potential after atrial fibrillation-induced electrical remodeling.
Tsujimae K; Murakami S; Kurachi Y
Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H793-800. PubMed ID: 18055524
[TBL] [Abstract][Full Text] [Related]
6. Synergistic Anti-arrhythmic Effects in Human Atria with Combined Use of Sodium Blockers and Acacetin.
Ni H; Whittaker DG; Wang W; Giles WR; Narayan SM; Zhang H
Front Physiol; 2017; 8():946. PubMed ID: 29218016
[TBL] [Abstract][Full Text] [Related]
7. Potassium Channel Blockade Enhances Atrial Fibrillation-Selective Antiarrhythmic Effects of Optimized State-Dependent Sodium Channel Blockade.
Aguilar M; Xiong F; Qi XY; Comtois P; Nattel S
Circulation; 2015 Dec; 132(23):2203-11. PubMed ID: 26499964
[TBL] [Abstract][Full Text] [Related]
8. Can inhibition of IKur promote atrial fibrillation?
Burashnikov A; Antzelevitch C
Heart Rhythm; 2008 Sep; 5(9):1304-9. PubMed ID: 18774108
[TBL] [Abstract][Full Text] [Related]
9. Atrial-selective K
Ravens U
Can J Physiol Pharmacol; 2017 Nov; 95(11):1313-1318. PubMed ID: 28738160
[TBL] [Abstract][Full Text] [Related]
10. Raloxifene inhibits transient outward and ultra-rapid delayed rectifier potassium currents in human atrial myocytes.
Liu H; Jin MW; Xiang JZ; Huang Y; Sun HY; Chiu SW; Lau CP; Li GR
Eur J Pharmacol; 2007 Jun; 563(1-3):61-8. PubMed ID: 17337266
[TBL] [Abstract][Full Text] [Related]
11. Atrial-Selective Potassium Channel Blockers.
Voigt N; Dobrev D
Card Electrophysiol Clin; 2016 Jun; 8(2):411-21. PubMed ID: 27261831
[TBL] [Abstract][Full Text] [Related]
12. Effects of new class III antiarrhythmic drug niferidil on electrical activity in murine ventricular myocardium and their ionic mechanisms.
Abramochkin DV; Kuzmin VS; Rosenshtraukh LV
Naunyn Schmiedebergs Arch Pharmacol; 2015 Oct; 388(10):1105-12. PubMed ID: 26105002
[TBL] [Abstract][Full Text] [Related]
13. Novel approaches for pharmacological management of atrial fibrillation.
Ehrlich JR; Nattel S
Drugs; 2009; 69(7):757-74. PubMed ID: 19441867
[TBL] [Abstract][Full Text] [Related]
14.
Ellinwood N; Dobrev D; Morotti S; Grandi E
Front Pharmacol; 2017; 8():799. PubMed ID: 29163179
[TBL] [Abstract][Full Text] [Related]
15. Ultrarapid Delayed Rectifier K
Hilderink S; Devalla HD; Bosch L; Wilders R; Verkerk AO
Front Cell Dev Biol; 2020; 8():536. PubMed ID: 32850774
[TBL] [Abstract][Full Text] [Related]
16. In humans, chronic atrial fibrillation decreases the transient outward current and ultrarapid component of the delayed rectifier current differentially on each atria and increases the slow component of the delayed rectifier current in both.
Caballero R; de la Fuente MG; Gómez R; Barana A; Amorós I; Dolz-Gaitón P; Osuna L; Almendral J; Atienza F; Fernández-Avilés F; Pita A; Rodríguez-Roda J; Pinto A; Tamargo J; Delpón E
J Am Coll Cardiol; 2010 May; 55(21):2346-54. PubMed ID: 20488306
[TBL] [Abstract][Full Text] [Related]
17. Pathology-specific effects of the IKur/Ito/IK,ACh blocker AVE0118 on ion channels in human chronic atrial fibrillation.
Christ T; Wettwer E; Voigt N; Hála O; Radicke S; Matschke K; Várro A; Dobrev D; Ravens U
Br J Pharmacol; 2008 Aug; 154(8):1619-30. PubMed ID: 18536759
[TBL] [Abstract][Full Text] [Related]
18. Pro-arrhythmogenic effects of atrial fibrillation-induced electrical remodelling: insights from the three-dimensional virtual human atria.
Colman MA; Aslanidi OV; Kharche S; Boyett MR; Garratt C; Hancox JC; Zhang H
J Physiol; 2013 Sep; 591(17):4249-72. PubMed ID: 23732649
[TBL] [Abstract][Full Text] [Related]
19. Antifibrillatory agents and potassium channels in the atria: pore block versus channel trafficking.
McEwen DP; Martens JR
Mol Interv; 2009 Apr; 9(2):79-86. PubMed ID: 19401540
[TBL] [Abstract][Full Text] [Related]
20. Populations of in silico myocytes and tissues reveal synergy of multiatrial-predominant K
Ni H; Fogli Iseppe A; Giles WR; Narayan SM; Zhang H; Edwards AG; Morotti S; Grandi E
Br J Pharmacol; 2020 Oct; 177(19):4497-4515. PubMed ID: 32667679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
